Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kelaibo Pharmaceutical Development is a specialized pharmaceutical research and development organization based in Beijing, China, focusing on the development of innovative drugs and high-end generic pharmaceuticals. The company provides a comprehensive suite of services including drug design, chemical synthesis, formulation research, and clinical trial coordination, primarily serving the domestic Chinese market. Kelaibo's therapeutic focus spans oncology, cardiovascular health, and metabolic diseases, where they leverage their expertise in small molecule chemistry. In addition to its role as a Contract Research Organization (CRO), the company engages in technology transfer and licensing of its internally developed drug candidates to larger pharmaceutical manufacturers. Their business model integrates independent R&D with technical services to accelerate the commercialization of complex therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kelaibo Pharmaceutical Development.